Only now the Natural Birth package is 2 000 PLN cheaper at Medicover Hospital!

Professional care during childbirth and comfortable stay conditions.

1500 visits available 1500 visits available
 3788 doctors 3788 doctors
1800 blood tests and services 1800 blood tests and services
Verified opinions Verified opinions
Mediclub

Thrombophilia - Expanded Panel (MTHFR + F2 + F5 + SERPINE-1)

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes the identification of mutations in the Factor V gene (F5), mutations in the Prothrombin gene (F2), and polymorphisms in the MTHFR gene.

Product to be shipped

Product to be shipped

To be done at home

To be done at home

Step-by-step instruction

Step-by-step instruction

Easy to use

Easy to use

PLN 439.00 PLN 417.05
Lowest price from 30 days before discounting PLN 417.05

Available in stock

Fast turnaround time

Secure courier delivery

Convenience and comfort of shopping

Fast shipping

Directly from the manufacturer

Secure payments

Blik, Przelewy24

Thrombophilia is defined as a predisposition to developing thrombosis. Thrombosis is a pathological process in which a blood clot forms within a blood vessel. When a clot forms in an artery, it is referred to as arterial thrombosis, and when it forms in a vein, it is called venous thrombosis. The most common sites of venous thrombosis are the veins in the lower limbs and pelvis. Clots forming in the coronary artery can lead to heart attacks. The predisposition to developing thrombosis can be hereditary or acquired.

Causes of Acquired Thrombophilia:

  • Antiphospholipid syndrome
  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Dermatomyositis
  • Infections and inflammatory conditions: ulcerative colitis, Crohn's disease
  • Cancer and chemotherapy: leukemia, lymphomas, colorectal cancer, lung cancer

Causes of Hereditary Thrombophilia:

  • Mutations in the factor V gene (F5)
  • Mutations in the factor II (prothrombin) gene (F2)
  • Deficiency of coagulation inhibitors caused by mutations in the genes: antithrombin (SERPINC1 gene mutation), protein C (PROC gene mutation), and protein S (PROS1 gene mutation). Antithrombin (AT), protein C (PC), and protein S (PS) are endogenous inhibitors of the coagulation process
  • Polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR)
  • Polymorphisms in plasminogen activator inhibitor-1 (PAI1)

Most Common Symptoms of Thrombosis:

  • Asymmetrically swollen limbs
  • Cyanosis of the feet and lower legs
  • Pain while walking
  • Pain and redness at the site of swelling
  • Dilated blood vessels
  • Increased heart rate
  • Chest pain

Purpose of the Test:

Identification of mutations in the patient's genetic material that predispose to thrombosis. The test includes identification of mutations in the Factor V gene (F5), Prothrombin gene (F2), and MTHFR gene polymorphism.

These mutations:

  • Are the most common cause of hereditary thrombophilia
  • Increase the risk of venous and arterial thrombosis, heart attack, stroke
  • Are causes of cardiovascular diseases, including thromboembolic complications

In pregnant women:

  • Increase the risk of recurrent miscarriages
  • May lead to premature placental abruption
  • May lead to the development of preeclampsia
  • May lead to fetal growth restriction
  • May lead to intrauterine fetal death
  • May lead to neural tube defects and cleft lip and palate in the fetus

Indications for the Test:

  • Symptoms of thromboembolic disease
  • Family history
  • Past episodes of thrombosis
  • Planned surgery involving prolonged immobilization
  • Recurrent miscarriages or stillbirths
  • Use of hormonal contraception
  • Use of hormone replacement therapy
  • Thrombocytopenia
  • Cancer
  • Sedentary lifestyle
  • Obesity
     

Method:

Real-time PCR
High sensitivity of the test – 99%
 

Sample Material:

EDTA blood

Oral swab

Recently viewed: